Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO
Accepted 2021-07-16 00:00:00 ET · period of report 2021-07-14 · accession 0001567619-21-013567 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-16 | 2021-07-14 | PRTA | HENNEY CHRISTOPHER S | Dir | S - Sale+OE | $55.46 | -11.1K | 2,000 | -85% | -$616.0K |
| D | 2021-07-16 | 2021-07-14 | PRTA | HENNEY CHRISTOPHER S | Dir | M - OptEx | $11.33 | +11.1K | 11.1K | New | +$125.9K |
| D | 2021-07-16 | 2021-07-14 | PRTA | HENNEY CHRISTOPHER S | Dir | M - OptEx | $0.00 | -11.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-14 | S | D | 2,000 | $56.13 | 0 | D | — | — | (F3) The transaction was executed in multiple trades in prices ranging from $56.005 to $56.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-14 | M | A | 11,108 | $11.33 | 11,108 | D | — | — | |
| 3 | Common | Ordinary Shares, par value $0.01 per share | 2021-07-14 | S | D | 9,108 | $55.31 | 2,000 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $55.00 to $55.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-07-14 | M | D | 11,108 | $0.00 | 0 | D | $11.33 · — to 2030-05-20 | 11,108 Ordinary Shares | (F4) The shares subject to the option were fully vested as of the date of the exercise. |